Prostatic Secretions and Drug Transport

Aumuller and Seitz (1990) have reviewed the secretory mechanism for the sex accessory tissues. Isaacs (1983) also reviewed the concepts related to the fluid and drug transport properties of the prostate and seminal vesicles and has compared the composition and volume of prostatic secretion under basal stimulation and under neurologic stimulation during ejaculation or pilocarpine stimulation. Isaacs calculated that under neurologic stimulation there is a 205-fold increase in the total potassium, chloride, and sodium output over the basal secretory rate, and he has shown that the prostate is capable of secreting five times its total content of sodium and chloride during this active secretion. These findings show the tremendous transport powers of this system. Smith and Hagopian (1981) have studied the transepithelial voltage changes during prostatic secretion in the dog and have concluded that although sodium may move passively through the plasma in the prostatic fluid during ejaculation the movements of potassium and chloride ions involve active transcellular transport. Isaacs and associates (1983) have shown that the androgen-induced secretions can be blocked in the presence of estrogen, although the growth properties and biologic properties of the androgen on the prostate are not markedly altered. This would suggest a direct effect of estrogen in blocking a major transport system in the prostate.

Only a few compounds, including ethanol, iodine, and a few antibiotics, are capable of entering the semen by simple diffusion (Reeves, 1982). Drugs entering prostatic secretions have been of interest because of the prevalence of prostatitis and the need for new modalities of chemotherapy. Earlier, Stamey and colleagues had made extensive studies of the ability of chemotherapeutic agents to concentrate in the prostatic fluid of humans and dogs (Hessl and Stamey, 1971; Stamey et al, 1973), and many other investigators have also contributed to this knowledge (Madsen et al, 1968, 1978; Madsen, 1976; Fowler et al, 1982). Few drugs reach concentrations in the prostatic secretion that approach or surpass their concentrations in blood, but some exceptions are the basic macrolides erythromycin and oleandomycin, sulfonamides, chloramphenicol, tetracycline, clindamycin, trimethoprim, and fluoroquinolones (Reeves, 1982).

In general these drugs are assumed to pass across the membrane by nonionic diffusion, possibly by lipid solubility, through the membrane; when they reach the more acidic prostatic fluid they are protonated and acquire a more positive charge. Thus the charged drugs become relatively trapped within the prostatic secretions. Several factors are critical, including the pKa of the drug and the pH of the prostatic secretions, as well as the drug binding to proteins in each compartment. Basic drugs would be more positively charged in acidic prostatic fluid than in blood. Slight changes in pH can have large effects on this nonionic diffusion. Samples of prostatic secretions from humans varied widely in pH from 6 to 8, with a mean value of 6.6; however, with prostatic inflammation the pH tended to be 7 or higher (White, 1975). Although prostatic secretions are slightly acidic, the pH of freshly ejaculated human semen is slightly alkaline (pH 7.3 to 7.7); on standing, semen first becomes more alkaline with the loss of carbon dioxide and then later acidic owing to accumulation of lactic acid. Drugs may be developed in the future that are transported into the prostate as therapeutic agents, as chemoprotectors, or as a route to the semen to regulate fertility; however, more must be learned about the fundamental transport system in and out of the male reproductive tract before such an approach is feasible.

Suggested Readings

Berezney R, Coffey DS. Nuclear matrix: isolation and characterization of a framework structure from rat liver nuclei. J Cell Biol. 1977;73:616-637.

Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120:513-522.

Cunha GR, Ricke W, Thomson A, et al. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol. 2004;92:221-236.

Clement JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family—from mice to men—what have we learnt in the last two decades? Biol Chem. 2008;389:1447-1454.

de Lamirande E. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost. 2007;33:60-68.

De Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell featuresof benign and malignant prostate epithelial cells. J Urol. 1998;160:2381-2392.

Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48:1198-1205.

Dinant C, Houtsmuller AB, Vermeulen W. Chromatin structure and DNA damage repair. Epigenetics Chromatin. 2008;1(1):9.

Hayward SW. Approaches to modeling stromal-epithelial interactions. J Urol. 2002;168:1165-1172.

Josson M, Lundwall A, Malm J. The semenogelins: proteins and functions beyond reproduction? Cell Mol Life Sci. 2006;63:2886-2888.

Luke MC, Coffey DS. The male sex accessory tissues: structure, androgen action and physiology. In: Knobil E, Neill JD, editors. The physiology of reproduction. 2nd ed. New York: Raven Press; 1994:1435-1487.

Lawson DA, Xin L, et al. Prostate stem cells and prostate cancer. Cold Spring Harb Symp Quant Biol. 2005;70:187-196.

Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code. Curr Opin Genet Dev. 2005;15:163-176.

Matusik RJ, Jin RJ, Sun Q, et al. Prostate epithelial cell fate. Differentiation. 2008;76:682-698.

Poliakov A, Spilman M, Dokland T, et al. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate. 2009;69:159-167.

Pollard KJ, Peterson CL. Chromatin remodeling: a marriage between two families? Bioessays. 1998;20:771-780.

Schaeffer EM, Marchionni L, et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008;27(57):7180-7191.

Thomson AA. Mesenchymal mechanisms in prostate organogenesis. Differentiation. 2008;76(6):587-598.

References

Abate-Shen C, Shen MM, et al. Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Differentiation. 2008;76(6):717-727.

Ablin RJ, Soanes WA, et al. Precipitating antigens of the normal human prostate. J Reprod Fertil. 1970;22(3):573-574.

Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer. 1999;6(4):503-519.

Ahmed K, Goueli SA. Androgen regulation of prostatic protein phosphokinases and protein phosphorylation. Biochem Actions Horm. 1987;14:237-291.

Ahmed K, Yenice S, et al. Association of casein kinase 2 with nuclear chromatin in relation to androgenic regulation of rat prostate. Proc Natl Acad Sci U S A. 1993;90(10):4426-4430.

Albelva S. Role of cell adhesion molecules in tumor progression and metastatic. London: Academic Press; 1994. p. 71–84

Alexander RB, Greene GL, et al. Estrogen receptors in the nuclear matrix: direct demonstration using monoclonal antireceptor antibody. Endocrinology. 1987;120(5):1851-1857.

Alexander RB, Propert KJ, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004;141(8):581-589.

Amelar RD. Coagulation, liquefaction and viscosity of human semen. J Urol. 1962;87:187-190.

Amelar RD, Dubin L, et al. Male infertility practice and Orthodox Jewish law. Urology. 1977;10(2):177-180.

Amelar RD, Hotchkiss RS. The split ejaculate: its use in the management of male infertility. Fertil Steril. 1965;16:46-60.

An G, Meka CS, et al. Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology. 1999;54(6):1105-1111.

Anahi Franchi N, Avendano C, et al. beta-Microseminoprotein in human spermatozoa and its potential role in male fertility. Reproduction. 2008;136(2):157-166.

Anderson KM, Liao S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature. 1968;219(151):277-279.

Andersson S, Berman DM, et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature. 1991;354(6349):159-161.

Arcadi JA. Role of the ground substance in atrophy of normal and malignant prostatic tissue following estrogen administration and orchiectomy. J Clin Endocrinol Metab. 1954;14(10):1113-1125.

Arienti G, Saccardi C, et al. Distribution of lipid and protein in human semen fractions. Clin Chim Acta. 1999;289(1–2):111-120.

Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem. 1993;39(2):181-195.

Aumailley M, Bruckner-Tuderman L, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24(5):326-332.

Aumuller G, Leonhardt M, et al. Semiquantitative morphology of human prostatic development and regional distribution of prostatic neuroendocrine cells. Prostate. 2001;46(2):108-115.

Aumuller G, Seitz J. Protein secretion and secretory processes in male accessory sex glands. Int Rev Cytol. 1990;121:127-231.

Aumuller G, Seitz J, et al. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate. 1990;17(1):31-40.

Barrack ER. Steroid hormone receptor localization in the nuclear matrix: interaction with acceptor sites. J Steroid Biochem. 1987;27(1–3):115-121.

Barrack ER, Coffey DS. The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J Biol Chem. 1980;255(15):7265-7275.

Barrack ER, Coffey DS. Biological properties of the nuclear matrix: steroid hormone binding. Recent Prog Horm Res. 1982;38:133-195.

Beck F, Tata F, et al. Homeobox genes and gut development. Bioessays. 2000;22(5):431-441.

Beckett ML, Cazares LH, et al. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer. Clin Cancer Res. 1999;5(12):4034-4040.

Bedwal RS, Bahuguna A. Zinc, copper and selenium in reproduction. Experientia. 1994;50(7):626-640.

Ben-Josef E, Yang SY, et al. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR). J Urol. 1999;161(3):970-976.

Benten WP, Lieberherr M, et al. Testosterone induces Ca2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett. 1997;407(2):211-214.

Berezney R, Coffey DS. Nuclear matrix: isolation and characterization of a framework structure from rat liver nuclei. J Cell Biol. 1977;73(3):616-637.

Berg T, Bradshaw RA, et al. A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions Suppl. 1992;38(Pt. 1):19-25.

Berman DM, Desai N, et al. Roles for hedgehog signaling in androgen production and prostate ductal morphogenesis. Dev Biol. 2004;267(2):387-398.

Berman DM, Tian H, et al. Expression and regulation of steroid 5 alpha-reductase in the urogenital tract of the fetal rat. Mol Endocrinol. 1995;9(11):1561-1570.

Berquin IM, Min Y, et al. Expression signature of the mouse prostate. J Biol Chem. 2005;280(43):36442-36451.

Bhatia B, Maldonado CJ, et al. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem. 2003;278(27):25091-25100.

Bhatia-Gaur R, Donjacour AA, et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999;13(8):966-977.

Bieberich CJ, Fujita K, et al. Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem. 1996;271(50):31779-31782.

Bing C, Bao Y, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A. 2004;101(8):2500-2505.

Birckbichler PJ, Bonner RB, et al. Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma. Cancer. 2000;89(2):412-423.

Bissell MJ, Hall HG, et al. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99(1):31-68.

Black BE, Paschal BM. Intranuclear organization and function of the androgen receptor. Trends Endocrinol Metab. 2004;15(9):411-417.

Blenk H, Hofstetter A. Complement C3, coeruloplasmin and PMN-elastase in the ejaculate in chronic prostato-adnexitis and their diagnostic value. Infection. 1991;19(Suppl. 3):S138-S140.

Boccardo F, Rubagotti A, et al. Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer. Prostate. 2003;55(4):259-264.

Bondar OP, Barnidge DR, et al. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem. 2007;53(4):673-678.

Borgono CA, Grass L, et al. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Res. 2003;63(24):9032-9041.

Brar PK, Dalkin BL, et al. Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal benign prostate glands and adult benign and malignant prostate glands. Prostate. 2003;55(1):65-70.

Bruchovsky N, Dunstan-Adams E. Regulation of 5α-reductase activity in stroma and epithelium of human prostate. In: Bruchovsky N, Chapdelaine A, Neumann F, editors. Regulation of androgen action. Berlin: Congressdruck R. Bruckner; 1985:31-34.

Bruchovsky N, Wilson JD. The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem. 1968;243(8):2012-2021.

Bunge RG. Some observations on the male ejaculate. Fertil Steril. 1970;21(9):639-644.

Bunge RG, Sherman JK. Liquefaction of human semen by alpha-amylase. Fertil Steril. 1954;5(4):353-356.

Burger PE, Xiong X, et al. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A. 2005;102(20):7180-7185.

Burgi W, Schmid K. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem. 1961;236:1066-1074.

Burgi W, Simonen S, et al. Unusually high concentrations of Zn alpha 2-glycoprotein and the lack of alpha 2HS-glycoprotein in human ejaculates. Clin Chem. 1989;35(8):1649-1650.

Burnett AL, Chan DW, et al. The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer. J Urol. 1962;148(6):1832-1834.

Burton RM, Westphal U. Steroid hormone-binding proteins in blood plasma. Metabolism. 1972;21(3):253-276.

Byar DP. Zinc in male sex accessory organs: distribution and hormonal response. New York: Academic Press; 1974. p. 161–171

Carbini LA, Scicli AG, et al. The molecular biology of the kallikrein-kinin system: III. The human kallikrein gene family and kallikrein substrate. J Hypertens. 1993;11(9):893-898.

Carter DB, Resnick MI. High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate. 1982;3(1):27-33.

Catalona WJ, Partin AW, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA. 1998;279(19):1542-1547.

Catalona WJ, Smith DS, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324(17):1156-1161.

Centenera MM, Harris JM, et al. The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol Endocrinol. 2008;22(11):2373-2382.

Chan DW, Bruzek DJ, et al. Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Clin Chem. 1987;33(10):1916-1920.

Chan PS, Chan LW, et al. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate. 1999;41(2):99-109.

Chandler JA, Timms BG, et al. Subcellular distribution of zinc in rat prostate studied by x-ray microanalysis: I. Normal prostate. Histochem J. 1977;9(1):103-120.

Chandran SS, Banerjee SR, et al. Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA). Cancer Biol Ther. 2008;7(6):974-982.

Chang C, Saltzman A, et al. Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr. 1995;5(2):97-125.

Chang CS, Kokontis J, et al. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science. 1988;240(4850):324-326.

Chang CS, Kokontis J, et al. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A. 1988;85(19):7211-7215.

Chang SS, O’Keefe DS, et al. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5(10):2674-2681.

Chang SS, Reuter VE, et al. Five different anti–prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999;59(13):3192-3198.

Chang SS, Reuter VE, et al. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology. 2001;57(4):801-805.

Chaudry AA, Wahle KW, et al. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer. 1994;57(2):176-180.

Chow PH, Chan CW, et al. Contents of fructose, citric acid, acid phosphatase, proteins and electrolytes in secretions of the accessory sex glands of the male golden hamster. Int J Androl. 1993;16(1):41-45.

Christensson A, Bjork T, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 1993;150(1):100-105.

Chu TM, Wang MC, et al. Enzyme markers in human prostatic carcinoma. Cancer Treat Rep. 1977;61(2):193-200.

Ciejek EM, Nordstrom JL, Tsai M, O’Malley BW. Ribonucleic acid precursors are associated with the chick oviduct nuclear matrix. Biochemistry. 1982;21:4945-4953.

Cipolla B, Guille F, et al. Erythrocyte polyamines and prognosis in stage D2 prostatic carcinoma patients. J Urol. 1994;151(3):629-633.

Clements JA. The human kallikrein gene family: a diversity of expression and function. Mol Cell Endocrinol. 1994;99(1):C1-C6.

Clements JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family—from mice to men—what have we learnt in the last two decades? Biol Chem. 2008;389(12):1447-1454.

Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am. 1990;17(3):461-475.

Cook C, Vezina CM, et al. Noggin is required for normal lobe patterning and ductal budding in the mouse prostate. Dev Biol. 2007;312(1):217-230.

Cosgrove MS, Boeke JD, et al. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol. 2004;11(11):1037-1043.

Cosgrove MS, Wolberger C. How does the histone code work? Biochem Cell Biol. 2005;83(4):468-476.

Costello LC, Franklin RB. Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate production. Prostate. 1989;15(4):335-342.

Costello LC, Franklin RB. Effect of prolactin on the prostate. Prostate. 1994;24(3):162-166.

Couse JE, Mahato D, et al. Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev. 2001;13(4):211-219.

Cunha GR. Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol. 1976;47:137-194.

Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer. 1994;74(3 Suppl.):1030-1044.

Cunha GR, Alarid ET, et al. Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl. 1992;13(6):465-475.

Cunha GR, Donjacour AA, et al. The endocrinology and developmental biology of the prostate. Endocr Rev. 1987;8(3):338-362.

Cunha GR, Hayward SW, et al. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 2003;107(1):1-10.

Cunha GR, Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool. 1978;205(2):181-193.

Cunha GR, Ricke W, et al. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol. 2004;92(4):221-236.

Curry PT, Atherton RW. Seminal vesicles: development, secretory products, and fertility. Arch Androl. 1990;25(2):107-113.

Daniels GFJr, Grayhack JT. Physiology of prostatic secretions. Sci Found Urol. 1990;3:351-358.

Darson MF, Pacelli A, et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology. 1997;49(6):857-862.

Davis MI, Bennett MJ, et al. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A. 2005;102(17):5981-5986.

Davis NS. Determination of serotonin and 5-hydroxyindoleacetic acid in guinea pig and human prostate using HPLC. Prostate. 1987;11(4):353-360.

Dawson RM, Mann T, et al. Glycerylphosphorylcholine and phosphorylcholine in semen, and their relation to choline. Biochem J. 1957;65(4):627-634.

de Lamirande E. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost. 2007;33(1):60-68.

de Lamirande E, Leclerc P, et al. Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization. Mol Hum Reprod. 1997;3(3):175-194.

de Lamirande E, Yoshida K, et al. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. J Androl. 2001;22(4):672-679.

De Marzo AM, Meeker AK, et al. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol. 1998;153(3):911-919.

De Marzo AM, Nelson WG, et al. Stem cell features of benign and malignant prostate epithelial cells. J Urol. 1998;160(6 Pt. 2):2381-2392.

DeKlerk DP, Human HJ. Fluctuations of prostatic glycosaminoglycans during fetal and pubertal growth. Prostate. 1985;6:169-175.

DeKlerk DP, Lee D, Human HJ. Glycosaminoglycans in human prostate cancer. J Urol. 1984;131:1008-1012.

Delker SL, West APJr, et al. Crystallographic studies of ligand binding by Zn-alpha2-glycoprotein. J Struct Biol. 2004;148(2):205-213.

Delves GH, Stewart AB, et al. Prostasomes, angiogenesis, and tissue factor. Semin Thromb Hemost. 2007;33(1):75-79.

Denis LJ, Prout GRJr. Lactic dehydrogenase in prostatic cancer. Invest Urol. 1963;96:101-111.

Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48(8):1198-1205.

Ding Z, Qu F, et al. Identification of sperm forward motility-related proteins in human seminal plasma. Mol Reprod Dev. 2007;74(9):1124-1131.

diSant-Agnese PA, deMesy-Jensen KL. Endocrine-paracrine cells of the prostate and prostatic urethra: an ultrastructural study. Hum Pathol. 1984;15:1034-1041.

diSant-Agnese PA, deMesy-Jensen KL, Churukien CJ, Agarwall MM. Human prostatic endocrine-paracrine (APUD) cells: distribution analysis for the comparison of serotonin and neuron-specific amylase immunoreactivity in silver stains. Arch Pathol Lab Med. 1985;109:607-612.

Doles J, Cook C, et al. Functional compensation in hedgehog signaling during mouse prostate development. Dev Biol. 2006;295(1):13-25.

Donjacour AA, Thomson AA, et al. FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol. 2003;261(1):39-54.

Donnelly BJ, Lakey WH, et al. Estrogen receptor in human benign prostatic hyperplasia. J Urol. 1983;130(1):183-187.

Douglas TH, Morgan TO, et al. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer. 1997;80(1):107-114.

Downs JA, Jackson SP. Cancer: protective packaging for DNA. Nature. 2003;424(6950):732-734.

Dubbink HJ, Cleutjens KB, et al. An Sp1 binding site is essential for basal activity of the human prostate-specific transglutaminase gene (TGM4) promoter. Gene. 1999;240(2):261-267.

Dubbink HJ, de Waal L, et al. The human prostate-specific transglutaminase gene (TGM4):genomic organization, tissue-specific expression, and promoter characterization. Genomics. 1998;51(3):434-444.

Dube JY, Frenette G, et al. Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as beta-inhibin. J Androl. 1987;8(3):182-189.

Economides KD, Capecchi MR. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development. 2003;130(10):2061-2069.

Edwards JJ, Tollaksen SL, et al. Proteins of human semen. I. Two-dimensional mapping of human seminal fluid. Clin Chem. 1981;27(8):1335-1340.

Elgamal AA, Holmes EH, et al. Prostate-specific membrane antigen (PSMA): current benefits and future value. Semin Surg Oncol. 2000;18(1):10-16.

Elhilali MM. Lactate dehydrogenase isoenzymes in hyperplasia and carcinoma of the prostate: a clinical study. J Urol. 1968;98:686-692.

Eliasson R. Studies on prostaglandin: occurrence, formation and biological actions. Acta Physiol Scand. 1959;46(Suppl. 158):1-73.

Eliasson R. Parameters of male infertility. New York: Harper & Row; 1973. p. 39–51

Elzanaty S, Erenpreiss J, et al. Seminal plasma albumin: origin and relation to the male reproductive parameters. Andrologia. 2007;39(2):60-65.

Emami N, Deperthes D, et al. Major role of human KLK14 in seminal clot liquefaction. J Biol Chem. 2008;283(28):19561-19569.

Emami N, Diamandis EP. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade: possible function in seminal plasma and skin. J Biol Chem. 2008;283(6):3031-3041.

Epstein JI, Netto G. Prostate biopsy interpretation. Philadelphia: Lippincott Williams & Wilkins; 2007.

Escriva H, Bertrand S, et al. The evolution of the nuclear receptor superfamily. Essays Biochem. 2004;40:11-26.

Espana F, Navarro S, et al. The role of protein C inhibitor in human reproduction. Semin Thromb Hemost. 2007;33(1):41-45.

Esposito C, Caputo I. Mammalian transglutaminases: identification of substrates as a key to physiological function and physiopathological relevance. FEBS J. 2005;272(3):615-631.

Etienne-Manneville S. Actin and microtubules in cell motility: which one is in control? Traffic. 2004;5(7):470-477.

Ewen ME. Where the cell cycle and histones meet. Genes Dev. 2000;14(18):2265-2270.

Faber PW, van Rooij HC, et al. Two different, overlapping pathways of transcription initiation are active on the TATA—less human androgen receptor promoter: the role of Sp1. J Biol Chem. 1993;268(13):9296-9301.

Fabiani R, Johansson L, et al. Prolongation and improvement of prostasome promotive effect on sperm forward motility. Eur J Obstet Gynecol Reprod Biol. 1995;58(2):191-198.

Fair WR, Couch J, et al. Prostatic antibacterial factor: identity and significance. Urology. 1976;7(2):169-177.

Fair WR, Couch J, et al. The purification and assay of the prostatic antibacterial factor (PAF). Biochem Med. 1993;8(2):329-339.

Fair WR, Israeli RS, et al. Prostate-specific membrane antigen. Prostate. 1997;32(2):140-148.

Fair WR, Parrish RF. Antibacterial substances in prostatic fluid. Prog Clin Biol Res. 1981;75A:247-264.

Farnsworth WE, Brown JR. Testosterone metabolism in the prostate. Natl Cancer Inst Monogr. 1963;12:323-329.

Fernandez JA, Heeb MJ. Role of protein C inhibitor and tissue factor in fertilization. Semin Thromb Hemost. 2007;33(1):13-20.

Finlay JA, Evans CL, et al. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology. 1998;51(5):804-809.

Flocks RH, Schmidt JD. Lactate dehydrogenase isoenzyme patterns of prostatic cancer and hyperplasia. J Surg Oncol. 1972;4(2):161-167.

Fondell JD, Brunel F, et al. Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression. Mol Cell Biol. 1996;16(1):281-287.

Forest MG, Rivarola MA, et al. Percentage binding of testosterone, androstenedione and dehydroisoandrosterone in human plasma. Steroids. 1968;12(3):323-343.

Fowler JEJr, Kaiser DL, et al. Immunologic response of the prostate to bacteriuria and bacterial prostatitis. I. Immunoglobulin concentrations in prostatic fluid. J Urol. 1982;128(1):158-164.

Freestone SH, Marker P, et al. Sonic hedgehog regulates prostatic growth and epithelial differentiation. Dev Biol. 2003;264(2):352-362.

Friberg J, Tilley-Friberg I. Antibodies in human seminal fluid. In: Hafez ESE, editor. Human semen and fertility regulation in men. St. Louis: Mosby; 1976:258-264.

Fu M, Rao M, et al. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J Biol Chem. 2004;279(28):29436-29449.

Fuchs AR, Chantharaski U. Prostaglandins and male fertility. In: Hafez ESE, editor. Human semen and fertility regulation in men. St. Louis: Mosby; 1976:187-197.

Gahankari DR, Golhar KB. An evaluation of serum and tissue bound immunoglobulins in prostatic diseases. J Postgrad Med. 1993;39(2):63-67.

Garde SV, Basrur VS, et al. Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate. 1999;38(2):118-125.

Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002;20(13):3001-3015.

Gerber HP, Seipel K, et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 1994;263(5148):808-811.

Getzenberg RH, Pienta KJ, et al. The tissue matrix: cell dynamics and hormone action. Endocr Rev. 1990;11(3):399-417.

Ghasriani H, Fernlund P, et al. A model of the complex between human beta-microseminoprotein and CRISP-3 based on NMR data. Biochem Biophys Res Commun. 2009;378(2):235-239.

Ghasriani H, Teilum K, et al. Solution structures of human and porcine beta-microseminoprotein. J Mol Biol. 2006;362(3):502-515.

Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem. 2004;91(3):528-539.

Giovannucci E, Rimm EB, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998;58(3):442-447.

Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14(2):121-141.

Goldstein AS, Lawson DA, et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008;105(52):20882-20887.

Goldsteyn ME, Hsieh JT, von Eschenbah AC. Phosphorylation status of the nuclear cytosolic androgen receptors in the rat ventral prostate. Prostate. 1989;14:91-101.

Gonzalez GF. Corrected seminal fructose test. Arch Androl. 1994;33:17-22.

Gonzalez GF, Kortebani G, Mazzolli AB. Hyperviscosity and hypofunction of the seminal vesicles. Arch Androl. 1993;30:63-88.

Good D, Schwarzenberger P, et al. Cloning and characterization of the prostate-specific membrane antigen promoter. J Cell Biochem. 1999;74(3):395-405.

Goueli SA, Holtzman JL, et al. Phosphorylation of the androgen receptor by a nuclear cAMP-independent protein kinase. Biochem Biophys Res Commun. 1984;123(2):778-784.

Govindan MV. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Mol Endocrinol. 1990;4(3):417-427.

Grauer LS, Lawler KD, et al. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM′ protein in the LNCaP prostatic carcinoma cell line. Cancer Res. 1998;58(21):4787-4789.

Grayhack JT, Lee C. Evaluation of prostatic fluid in prostatic pathology. Prog Clin Biol Res. 1981;75A:231-246.

Grayhack JT, Wendel EF, et al. Lactate dehydrogenase isoenzymes in human prostatic fluid: an aid in recognition of malignancy? J Urol. 1977;118(1 Pt. 2):204-208.

Grayhack JT, Wendel EF, et al. Analysis of specific proteins in prostatic fluid for detecting prostatic malignancy. J Urol. 1979;121(3):295-299.

Grisanzio C, Signoretti S. p63 in prostate biology and pathology. J Cell Biochem. 2008;103(5):1354-1368.

Grishina IB, Kim SY, et al. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol. 2005;288(2):334-347.

Gu W, Malik S, et al. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol Cell. 1999;3(1):97-108.

Gunn SA, Gould TC. The relative importance of androgen and estrogen in the selective uptake of Zn65 by the dorsolateral prostate of the rat. Endocrinology. 1956;58(4):443-452.

Gunn SA, Gould TC, et al. The effect of growth hormone and prolactin preparations on the control by interstitial cell-stimulating hormone of uptake of 65-Zn by the rat dorsolateral prostate. J Endocrinol. 1965;32:205-214.

Gutman AB, Gutman EB. An acid phosphatase occurring in serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest. 1938;17:473-478.

Habib FK, Ross M, et al. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia. Clin Endocrinol (Oxf). 1997;46(2):137-144.

Hagstrom J, Harvey S, et al. Androgens are necessary for the establishment of secretory protein expression in the guinea pig seminal vesicle epithelium. Biol Reprod. 1992;47(5):768-775.

Hallmann R, Horn N, et al. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev. 2005;85(3):979-1000.

Hammond GL. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J Endocrinol. 1978;78(1):7-19.

Han KR, Seligson DB, et al. Prostate stem cell antigen expression is associated with Gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol. 2004;171(3):1117-1121.

Hara N, Kasahara T, et al. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Clin Cancer Res. 2002;8(6):1794-1799.

Harvey S, Vrabel A, et al. Androgen regulation of an elastase-like protease activity in the seminal vesicle. Biol Reprod. 1995;52(5):1059-1065.

Hassan MI, Kumar V, et al. Purification and characterization of zinc alpha2-glycoprotein-prolactin inducible protein complex from human seminal plasma. J Sep Sci. 2008;31(12):2318-2324.

Hassan MI, Waheed A, et al. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res. 2008;6(6):892-906.

Hay ED. The cell biology of the extracellular matrix. New York: Plenum Press; 1981.

He S, Bauman D, et al. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis. Proc Natl Acad Sci U S A. 2003;100(21):12033-12038.

Heathcote JG, Washington RJ. Analysis of the zinc-binding protein derived from the human benign hypertrophic prostate. J Endocrinol. 1973;58:421-423.

Henttu P, Liao SS, et al. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology. 1992;130(2):766-772.

Hessl JM, Stamey TA. The passage of tetracyclines across epithelial membranes with special reference to prostatic epithelium. J Urol. 1971;106(2):253-256.

Heston WD. Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv. 1991;11:217-238.

Higgins JR, Gosling JA. Studies on the structure and intrinsic innervation of the normal human prostate. Prostate. 1989;Suppl.2:5-16.

Higgins SJ, Hemingway AL. Effects of androgens on the transcription of secretory protein genes in rat seminal vesicle. Mol Cell Endocrinol. 1991;76(1–3):55-61.

Hirai K, Hussey HJ, et al. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998;58(11):2359-2365.

Hogan BL. Morphogenesis. Cell. 1999;96(2):225-233.

Horoszewicz JS, Kawinski E, et al. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 1987;7(5B):927-935.

Horsfall DJ, Mayne K, et al. Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate. Prostate. 1994;25(6):320-332.

Horton RJ. Androgen hormones and prehormones in young and elderly men, Proceedings of a workshop sponsored by the Kidney Disease and Urology Program of the NIAMDD. Grayhack JT, Wilson JD, Scherbenske MJ, editors. Benign prostatic hyperplasia. U.S. Government Printing Office, Washington (DC), 1976, 183-188.

Huang ZQ, Li J, et al. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and mediator for transcription. Embo J. 2003;22(9):2146-2155.

Huggins C, Neal W. Proteolytic enzymes and citrate in prostatic fluid. J Exp Med. 1942;7:527-541.

Husmann DA, Wilson CM, et al. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology. 1990;126(5):2359-2368.

Huss WJ, Gray DR, et al. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate. 2004;60(2):77-90.

Iehle C, Delos S, et al. Human prostatic steroid 5 alpha-reductase isoforms—a comparative study of selective inhibitors. J Steroid Biochem Mol Biol. 1995;54(5–6):273-279.

Irvine RA, Ma H, et al. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet. 2000;9(2):267-274.

Isaacs JT. Prostatic structure and function in relation to the etiology of prostatic cancer. Prostate. 1983;4(4):351-366.

Isaacs JT, Barrack ER, et al. The relationship of cellular structure and function: the matrix system. Prog Clin Biol Res. 1981;75A:1-24.

Isaacs JT, Brendler CB, et al. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab. 1983;56(1):139-146.

Isaacs JT, Coffey DS. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia. Endocrinology. 1981;108(2):445-453.

Israeli RS, Powell CT, et al. Expression of the prostate-specific membrane antigen. Cancer Res. 1994;54(7):1807-1811.

Ito M, Yuan CX, et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell. 1999;3(3):361-370.

Jackson TA, Richer JK, et al. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol. 1997;11(6):693-705.

John H, Maake C, et al. Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity. Andrologia. 2003;35(5):294-299.

Johnson L, Wikstrom S, et al. The vehicle for zinc in the prostatic secretion of dogs. Scand J Urol Nephrol. 1969;3(1):9-11.

Jones RD, English KM, et al. Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin Sci (Lond). 2004;107(2):149-158.

Jonsson M, Linse S, et al. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem J. 2005;387(Pt. 2):447-453.

Jonsson M, Lundwall A, et al. The semenogelins: proteins with functions beyond reproduction? Cell Mol Life Sci. 2006;63(24):2886-2888.

Joshi RR, Jyothi S. Ab initio structure of human seminal plasma prostatic inhibin gives significant insight into its biological functions. J Mol Model (Online). 2002;8(2):50-57.

Kadmon D. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO). J Cell Biochem Suppl. 1992;16H:122-127.

Kallio PJ, Poukka H, Moilanen A, et al. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol. 1995;9(8):1017-1028.

Kavanagh JP. Isocitric and citric acid in human prostatic and seminal fluid: implications for prostatic metabolism and secretion. Prostate. 1994;24(3):139-142.

Kelly RW, Holland P, et al. Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol. 1991;86(3):550-556.

Kempinas WG, Petenusci SO, et al. The hypophyseal-testicular axis and sex accessory glands following chemical sympathectomy with guanethidine of pre-pubertal to mature rats. Andrologia. 1995;27(2):121-125.

Kemppainen JA, Lane MV, et al. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation: specificity for steroids and antihormones. J Biol Chem. 1992;267(2):968-974.

Kim JK, Kim DY, et al. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil. Magn Reson Imaging. 1998;16(10):1281-1288.

Kirchheim D, Gyoerkey F, et al. Histochemistry of the normal, hyperplastic, and neoplastic human prostate gland. Invest Urol. 1964;12:403-421.

Kmita M, Duboule D. Organizing axes in time and space; 25 years of colinear tinkering. Science. 2003;301(5631):331-333.

Knox JD, Cress AE, et al. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol. 1994;145(1):167-174.

Kofoed JA, Tumilasci OR, et al. Effects of castration and androgens upon prostatic proteoglycans in rats. Prostate. 1990;16(2):93-102.

Kondo T, Zakany J, et al. Of fingers, toes and penises. Nature. 1997;390(6655):29.

Konety BR, Getzenberg RH. Nuclear structural proteins as biomarkers of cancer. J Cell Biochem (Suppl.). 1999;32–33:183-191.

Kuiper GG, Faber PW, et al. Structural organization of the human androgen receptor gene. J Mol Endocrinol. 1989;2(3):R1-R4.

Kumar A, Goel AS, et al. Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res. 1996;56(23):5397-5402.

Kuriyama M, Wang MC, Papsidero LD, Killians CS. Quantitation of prostatic specific antigen serum by a sensitive enzyme immunoassay. Cancer Res. 1980;40:4658-4662.

Kuriyama M, Wang MC, Papsidero LD, Lee CL. Use of human prostate specific antigen in monitoring prostate cancer. Cancer Res. 1981;41:3874-3876.

Kwong J, Xuan JW, et al. A comparative study of hormonal regulation of three secretory proteins (prostatic secretory protein-PSP94, probasin, and seminal vesicle secretion II) in rat lateral prostate. Endocrinology. 2000;141(12):4543-4551.

Kyprianou N, Isaacs JT. Significance of measurable androgen levels in the rat following castration. Prostate. 1987;10:313-324.

Lam AL, Pazin DE, Sullivan BA. Control of gene expression and assembly of chromosomal subdomains by chromatin regulators with antagonistic functions. Chromosoma. 2005;114(4):242-251.

Lamano-Carvalho TL, Favaretto AL, et al. Prepubertal development of rat prostate and seminal vesicle following chemical sympathectomy with guanethidine. Braz J Med Biol Res. 1993;26(6):639-646.

Lamm ML, Catbagan WS, et al. Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol. 2002;249(2):349-366.

Lamm ML, Podlasek CA, et al. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol. 2001;232(2):301-314.

Landers JP, Spelsberg TC. New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr. 1992;2(1):19-63.

Lasnitzki I, Franklin HR. The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture. J Endocrinol. 1972;54(2):333-342.

Laspada A, Wilson E, Lubahn D. Androgen receptor gene mutation in X linked spinal and bulbar muscular atrophy. Nature. 1991;352:77-79.

Lawson DA, Xin L, et al. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A. 2007;104(1):181-186.

Le Calvé M, Segalen J, Quernee D, et al. Diamine oxidase activity and biochemical markers in human seminal plasma. Hum Reprod. 1995;10:1141-1144.

Leong KG, Gao WQ. The Notch pathway in prostate development and cancer. Differentiation. 2008;76(6):699-716.

Lepor H. Medical management of benign prostatic hyperplasia. Urology. 1993;42:483-501.

Lepor H, Kuhar MJ. Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. J Urol. 1984;132(2):397-402.

Lepor H, Tang R, et al. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Prostate. 1993;22(4):301-307.

Li HC, Chernoff J, et al. A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. Eur J Biochem. 1984;138(1):45-51.

Liang ZG, Kamada M, et al. Immunoglobulin-Fc binding factor in human male reproductive organs. Andrologia. 1981;23(6):435-437.

Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest. 1985;76(5):1899-1903.

Lilja H. Significance of different molecular forms of serum PSA: the free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin. Urol Clin North Am. 1993;20(4):681-686.

Lilja H. Structure, function, and regulation of the enzyme activity of prostate-specific antigen. World J Urol. 1993;11(4):188-191.

Lilja H, Abrahamsson PA. Three predominant proteins secreted by the human prostate gland. Prostate. 1988;12(1):29-38.

Lilja H, Christensson A, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem. 1991;37(9):1618-1625.

Lilja H, Oldbring J, et al. Seminal vesicle–secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest. 1987;80(2):281-285.

Lin MF, Clinton GM. Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity. Biochem J. 1986;235(2):351-357.

Lin Y, Liu G, et al. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development. 2007;134(4):723-734.

Liney GP, Lowry M, et al. Proton MR T2 maps correlate with the citrate concentration in the prostate. NMR Biomed. 1996;9(2):59-64.

Liney GP, Turnbull LW, et al. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging. 1997;15(10):1177-1186.

Liu AY, Nelson PS, et al. Human prostate epithelial cell-type cDNA libraries and prostate expression patterns. Prostate. 2002;50(2):92-103.

Liu H, Moy P, et al. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res. 1997;57(17):3629-3634.

Lodge PA, Childs RA, et al. Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cells. J Immunother. 1999;22(4):346-355.

Love RR, Carbone PP, et al. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst. 1993;85(9):732-737.

Lowe FC, Trauzzi SJ. Prostatic acid phosphatase in 1993: its limited clinical utility. Urol Clin North Am. 1993;20(4):589-595.

Lowry M, Liney GP, et al. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and age-related differences. Magn Reson Med. 1996;36(3):352-358.

Lu W, Luo Y, et al. Fibroblast growth factor-10: a second candidate stromal to epithelial cell andromedin in prostate. J Biol Chem. 1999;274(18):12827-12834.

Lubahn DB, Joseph DR, et al. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 1988;240(4850):327-330.

Luke MC, Coffey DS. The male sex accessory tissues: structure, androgen action and physiology. In: Knobil E, Neill JD, editors. The physiology of reproduction. 2nd ed. New York: Raven; 1994:1435-1487.

Lundwall A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun. 1989;161(3):1151-1159.

Lundwall A, Bjartell A, et al. Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. Mol Hum Reprod. 2002;8(9):805-810.

Lundwall A, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 1987;214(2):317-322.

Lupien M, Eeckhoute J, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132(6):958-970.

Lupold SE, Rodriguez R. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen. Mol Cancer Ther. 2004;3(5):597-603.

Lwaleed BA, Greenfield R, et al. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost. 2004;92(4):752-766.

Lynch MJ, Nicholson JK. Proton MRS of human prostatic fluid: correlations between citrate, spermine, and myo-inositol levels and changes with disease. Prostate. 1997;30(4):248-255.

MacDonald PC. Origin of estrogen in men, Proceedings of a workshop sponsored by the Kidney Disease and Urology Program of the NIAMDD. Grayhack JT, Wilson JD, Scherbenske MJ, editors. Benign prostatic hyperplasia. U.S. Government Printing Office, Washington (DC), 1976, 191-192.

Mackenzie AR, Hall T, et al. Zinc content of expressed human prostatic fluid. Nature. 1962;193:72-73.

Madhubala R, Pegg AE. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase synthesis by antisense oligodeoxynucleotides. Mol Cell Biochem. 1992;118(2):191-195.

Madsen PO, Baumueller A, et al. Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis (Suppl.). 1978;14:145-150.

Madsen PO, Kjaer B, Baumueller A, Mellin HE. Antimicrobial agents in prostatic fluid and tissue. Infection. 1976;4(Suppl. 2):154-156.

Madsen PO, Wolf H, et al. The nitrofurantoin concentration in prostatic fluid of humans and dogs. J Urol. 1968;100(1):54-56.

Mahadevan D, Saldanha JW. The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: implications for drug design. Protein Sci. 1999;8(11):2546-2549.

Mahendroo MS, Russell DW. Male and female isoenzymes of steroid 5alpha-reductase. Rev Reprod. 1999;4(3):179-183.

Malm J, Hellman J, et al. Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur J Biochem. 1996;238(1):48-53.

Mann T, Mann CL. Male reproductive function and semen. New York: Springer-Verlag; 1981.

Marcelli M, Tilley WD, et al. Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol Endocrinol. 1990;4(8):1105-1116.

Margueron R, Trojer P, et al. The key to development: interpreting the histone code? Curr Opin Genet Dev. 2005;15(2):163-176.

Marker PC. Does prostate cancer co-opt the developmental program? Differentiation. 2008;76(6):736-744.

Marriman EC, Van Venrooij WJ. The nuclear matrix and RNA processing: use of human antibodies. New York: Alan R. Liss; 1985.

Marshall TW, Link KA, et al. Differential requirement of SWI/SNF for androgen receptor activity. J Biol Chem. 2003;278(33):30605-30613.

Matusik RJ, Jin RJ, et al. Prostate epithelial cell fate. Differentiation. 2008;76(6):682-698.

McConnell JD. Prostatic growth: new insights into hormonal regulation. Br J Urol. 1995;76(Suppl. 1):5-10.

McCormack RT, Rittenhouse HG, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995;45(5):729-744.

McKenna NJ, Lanz RB, et al. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999;20(3):321-344.

McKeon F. p63 and the epithelial stem cell: more than status quo? Genes Dev. 2004;18(5):465-469.

McMullen BA, Fujikawa K, et al. Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry. 1991;30(8):2050-2056.

McMullin RP, Mutton LN, et al. Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis. Dev Dyn. 2009;238(3):664-672.

Metzger DA, Korach KS. Cell-free interaction of the estrogen receptor with mouse uterine nuclear matrix: evidence of saturability, specificity, and resistance to KCl extraction. Endocrinology. 1990;126(4):2190-2195.

Mikolajczyk SD, Millar LS, et al. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate. 1998;34(1):44-50.

Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255-284.

Mizokami A, Yeh SY, et al. Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol. 1994;8(1):77-88.

Mobbs BG, Johnson IE, et al. Influence of the adrenal gland on prostatic activity in adult rats. J Endocrinol. 1973;59(2):335-344.

Moilanen AM, Poukka H, et al. Identification of a novel RING finger protein as a coregulator in steroid receptor–mediated gene transcription. Mol Cell Biol. 1998;18(9):5128-5139.

Murphy GP, Elgamal AA, et al. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer. 1998;83(11):2259-2269.

Murphy GP, Troychak MJ, et al. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. Prostate. 1997;33(2):141-146.

Naar AM, Beaurang PA, et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 1999;398(6730):828-832.

Nair SC, Toran EJ, et al. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress Chaperones. 1996;1(4):237-250.

Nakamura T, Scorilas A, et al. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res. 2003;63(19):6543-6546.

Naslund MJ, Coffey DS. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J Urol. 1986;136(5):1136-1140.

Naslund MJ, Coffey DS. Benign prostatic hyperplasia. U.S. Dept of Health and Human Services, NIH publication 2(87–2881). Bethesda, MD: National Institutes of Health; 1987.

Nelson PS, Gan L, et al. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci U S A. 1999;96(6):3114-3119.

Nelson WG, Pienta KJ, et al. The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Chem. 1986;15:457-475.

Niemi M, Harkonen M, et al. Enzymic histochemistry of human prostate: localization of oxidative enzymes, esterase, and aminopeptidase in the normal and hyperplastic human prostate. Arch Pathol. 1963;75:528-537.

Nolet S, St-Louis D, et al. Rapid evolution of prostatic protein PSP94 suggested by sequence divergence between rhesus monkey and human cDNAs. Genomics. 1991;9(4):775-777.

O’Malley B. The year in basic science: nuclear receptors and coregulators. Mol Endocrinol. 2008;22(12):2751-2758.

Obiezu CV, Diamandis EP. Human tissue kallikrein gene family: applications in cancer. Cancer Lett. 2005;224(1):1-22.

Ochiai Y, Inazawa J, et al. Human gene for beta-microseminoprotein: its promoter structure and chromosomal localization. J Biochem. 1995;117(2):346-352.

Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145(5):907-923.

Oesterling JE. PSA leads the way for detecting and following prostate cancer. Contemp Urol. 1993;5(2):60-81.

Oesterling JE, Chan DW, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988;139(4):766-772.

Oesterling JE, Epstein JI, et al. The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism. J Urol. 1986;136(5):1030-1034.

Olafsen T, Gu Z, et al. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. J Immunother. 2007;30(4):396-405.

Olin EH, Fabiana R, Johansson L, Ronquist G. Arachidonic acid 15-lipoxygenase traces of E prostaglandins in purified human prostasomes. J Reprod Fertil. 1993;99:195-199.

Oliver JA, el-Hilali MM, et al. LDH isoenzymes in benign and malignant prostate tissue: the LDH V-I ratio as an index of malignancy. Cancer. 1970;25(4):863-866.

Palvimo JJ, Kallio PJ, et al. Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol Endocrinol. 1993;7(11):1399-1407.

Pardoll DM, Vogelstein B, et al. A fixed site of DNA replication in eucaryotic cells. Cell. 1980;19(2):527-536.

Partin AW, Carter HB. The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer. Urol Clin North Am. 1996;23(4):531-540.

Partin AW, Carter HB, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990;143(4):747-752.

Partin AW, Catalona WJ, et al. Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology. 1999;54(5):839-845.

Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol. 1994;152(5 Pt. 1):1358-1368.

Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell. 1997;88(6):737-740.

Peehl DM. Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer. 2005;12(1):19-47.

Peitz B, Olds-Clarke P. Effects of seminal vesicle removal on fertility and uterine sperm motility in the house mouse. Biol Reprod. 1986;35(3):608-617.

Peter A, Lilja H, et al. Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur J Biochem. 1998;252(2):216-221.

Peterson CL, Tamkun JW. The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci. 1995;20(4):143-146.

Peterziel H, Mink S, et al. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene. 1999;18(46):6322-6329.

Phadke AM, Samant NR, et al. Significance of seminal fructose studies in male infertility. Fertil Steril. 1973;24(11):894-903.

Phelan ML, Schnitzler GR, et al. Octamer transfer and creation of stably remodeled nucleosomes by human SWI-SNF and its isolated ATPases. Mol Cell Biol. 2000;20(17):6380-6389.

Pienta KJ, Murphy BC, Getzenberg RH, Coffey DS. The tissue matrix and the regulation of gene expression in cancer cell. Adv Mol Cell Biol. 1993;7:131-156.

Podlasek CA, Barnett DH, et al. Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol. 1999;209(1):28-39.

Podlasek CA, Duboule D, et al. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn. 1997;208(4):454-465.

Polascik TJ, Oesterling JE, et al. Prostate specific antigen: a decade of discovery—what we have learned and where we are going. J Urol. 1999;162(2):293-306.

Poliakov A, Spilman M, et al. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate. 2009;69(2):159-167.

Pollard KJ, Peterson CL. Chromatin remodeling: a marriage between two families? Bioessays. 1998;20(9):771-780.

Poortmans JR, Schmid K. The level of Zn-alpha 2-glycoprotein in normal human body fluids and kidney extract. J Lab Clin Med. 1968;71(5):807-811.

Porter AT, F A C R OBen-Josef E. Humoral mechanisms in prostate cancer: a role for FSH. Urol Oncol. 2001;6(4):131-138.

Poukka H, Karvonen U, et al. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci. 2000;113(Pt. 17):2991-3001.

Poulos A, Voglmayr JK, et al. Phospholipid changes in spermatozoa during passage through the genital tract of the bull. Biochim Biophys Acta. 1973;306(2):194-202.

Pourian MR, Kvist U, et al. Rapid and slow hydroxylators of seminal E prostaglandins among men in barren unions. Andrologia. 1995;27(2):71-79.

Powers CA, Mathur M, et al. TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol Endocrinol. 1998;12(1):4-18.

Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 1997;18(3):306-360.

Price D. Comparative aspects of development and structure in the prostate. Natl Cancer Inst Monogr. 1963;12:1-27.

Prins GS, Birch L. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology. 1995;136(3):1303-1314.

Prins GS, Birch L, et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001;61(16):6089-6097.

Pritchard C, Mecham B, et al. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Res. 2009;69(5):1739-1747.

Propping D, Tauber PF, Zaneveld LJD, Schumacher GFB. Purification and characterization of two plasminogen activators from human seminal plasma. Fed Proc. 1974;33:289-293.

Pucar D, Shukla-Dave A, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology. 2005;236(2):545-553.

Rachez C, Suldan Z, et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 1998;12(12):1787-1800.

Rackley RR, Yang B, et al. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia. Cancer. 1991;68(3):587-593.

Raff AB, Gray A, et al. Prostate stem cell antigen: a prospective therapeutic and diagnostic target. Cancer Lett. 2009;277(2):126-132.

Rajasekaran AK, Anilkumar G, et al. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol. 2005;288(5):C975-C981.

Rajfer J, Coffey DS. Sex steroid imprinting of the immature prostate: long-term effects. Invest Urol. 1978;16(3):186-190.

Rajfer J, Coffey DS. Effects of neonatal steroids on male sex tissues. Invest Urol. 1979;17(1):3-8.

Rao MA, Cheng H, et al. RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J Biol Chem. 2002;277(50):48020-48027.

Reed MJ, Stitch SR. The uptake of testosterone and zinc in vitro by the human benign hypertrophic prostate. J Endocrinol. 1973;58(3):405-419.

Reeves DS. Pharmacology of the prostate. In: Chisholm GD, Williams DI, editors. Scientific foundations of urology. 2nd ed. London: William Heinemann; 1982:514-520.

Reeves R, Beckerbauer LM. HMGA proteins as therapeutic drug targets. Prog Cell Cycle Res. 2003;5:279-286.

Reigman PHF, Vliestra RJ, Suurmeijer L, et al. Characterization of the human kallikrein locus. Genomics. 1992;14:6-11.

Reiter RE, Gu Z, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A. 1998;95(4):1735-1740.

Risbridger GP, Almahbobi GA, et al. Early prostate development and its association with late-life prostate disease. Cell Tissue Res. 2005;322(1):173-181.

Rittenhouse HG, Finlay JA, et al. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci. 1998;35(4):275-368.

Rittmaster RS. Finasteride. N Engl J Med. 1994;330(2):120-125.

Roche PJ, Hoare SA, et al. A consensus DNA-binding site for the androgen receptor. Mol Endocrinol. 1992;6(12):2229-2235.

Rochon YP, Horoszewicz JS, et al. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Prostate. 1994;25(4):219-223.

Rohan TE, Howe GR, et al. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control. 1995;6(2):145-154.

Rokhlin OW, Cohen MB. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate. 1995;26(4):205-212.

Romas NA, Kwan DJ. Prostatic acid phosphatase: biomolecular features and assays for serum determination. Urol Clin North Am. 1993;20(4):581-588.

Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta. 1985;822(2):203-218.

Rose DP, Connolly JM. Dietary fat, fatty acids and prostate cancer. Lipids. 1992;27(10):798-803.

Ross JS, Sheehan CE, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res. 2003;9(17):6357-6362.

Roy AV, Brower ME, et al. Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem. 1971;17(11):1093-1102.

Rui H, Mevag B, et al. Two-dimensional electrophoresis of proteins in various fractions of the human split ejaculate. Int J Androl. 1984;7(6):509-520.

Russell DW, Wilson JD. Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem. 1994;63:25-61.

Russell ST, Tisdale MJ. The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer. 2005;92(5):876-881.

Ryu S, Zhou S, et al. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature. 1999;397(6718):446-450.

Sadar MD, Hussain M, et al. Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer. 1999;6(4):487-502.

Saedi MS, Zhu Z, et al. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Int J Cancer. 2001;94(4):558-563.

Salm SN, Burger PE, et al. TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol. 2005;170(1):81-90.

Sanchez LM, Chirino AJ, et al. Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science. 1999;283(5409):1914-1919.

Sansone G, Martino M, et al. Binding of free and protein-associated zinc to rat spermatozoa. Comp Biochem Physiol C. 1991;99(1–2):113-117.

Saporita AJ, Zhang Q, et al. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem. 2003;278(43):41998-42005.

Savory JG, Hsu B, et al. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol. 1999;19(2):1025-1037.

Schaeffer EM, Marchionni L, et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008;27(57):7180-7191.

Schalken JA, van Leenders G. Cellular and molecular biology of the prostate: stem cell biology. Urology. 2003;62(5 Suppl. 1):11-20.

Scheidler J, Hricak H, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology. 1999;213(2):473-480.

Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol. 2007;8(12):970-982.

Schoenmakers E, Verrijdt G, et al. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem. 2000;275(16):12290-12297.

Scott WW. The lipids of prostatic fluid, seminal plasma and enlarged prostate gland of man. J Urol. 1945;53:712-718.

Seamonds B, Yang N, et al. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology. 1986;28(6):472-479.

Seligman AM, Chauncey HH, et al. The colorimetric determination of phosphatases in human serum. J Biol Chem. 1951;190(1):7-15.

Seligman AM, Sternberger NJ, et al. Design of spindle poisons activated specifically by prostatic acid phosphatase (PAP) and new methods for PAP cytochemistry. Cancer Chemother Rep. 1975;59(1):233-242.

Serkova NJ, Gamito EJ, et al. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate. 2008;68(6):620-628.

Shaffer PL, Jivan A, et al. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A. 2004;101(14):4758-4763.

Shappell SB, Boeglin WE, et al. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol. 1999;155(1):235-245.

Sharma M, Zarnegar M, et al. Androgen receptor interacts with a novel MYST protein, HBO1. J Biol Chem. 2000;275(45):35200-35208.

Shaw A, Bushman W. Hedgehog signaling in the prostate. J Urol. 2007;177(3):832-838.

Sheflin L, Keegan B, et al. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun. 2000;276(1):144-150.

Shellhammer PF, Wright GLJr. Biomolecular and clinical characteristics of PSA and other candidate prostate tumor makers. Urol Clin North Am. 1993;20:597-606.

Shukeir N, Arakelian A, et al. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res. 2003;63(9):2072-2078.

Signoretti S, Waltregny D, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157(6):1769-1775.

Sikes RA, Kao C, Chung LWK. Autocrine and paracrine mediators for prostate growth in cancer progression. Adv Urol. 1995;8:21-60.

Silver DA, Pellicer I, et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):81-85.

Silver RI, Wiley EL, et al. Cell type specific expression of steroid 5 alpha-reductase 2. J Urol. 1994;152(2 Pt. 1):438-442.

Singh J, Zhu Q, et al. Stereological evaluation of mouse prostate development. J Androl. 1999;20(2):251-258.

Sinha AA, Gleason DF, et al. Immunohistochemical localization of laminin in the basement membranes of normal, hyperplastic, and neoplastic human prostate. Prostate. 1989;15(4):299-313.

Smith DF. Chaperones in progesterone receptor complexes. Semin Cell Dev Biol. 2000;11(1):45-52.

Smith ER, Hagopian M. Uptake and secretion of carcinogenic chemicals by the dog and rat prostate. Prog Clin Biol Res. 1981;75B:131-163.

Sokoloff RL, Norton KC, et al. A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine. Prostate. 2000;43(2):150-157.

Stamey TA, Bushby SR, et al. The concentration of trimethoprim in prostatic fluid: nonionic diffusion or active transport? J Infect Dis. 1973;128(Suppl.):686-692.

Stamey TA, Fair WR, et al. Antibacterial nature of prostatic fluid. Nature. 1968;218(140):444-447.

Stamey TA, Yang N, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317(15):909-916.

Steiner MS. Growth factors in urology. Urology. 1993;42:99-110.

Stenman UH, Leinonen J, Alfthan H, et al. A complex antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51:222-226.

Su SL, Huang IP, et al. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res. 1995;55(7):1441-1443.

Sudarsanam P, Winston F. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet. 2000;16(8):345-351.

Sugimura Y, Cunha GR, et al. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod. 1986;34(5):961-971.

Sun X, Zhang Y, et al. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol Cell. 1998;2(2):213-222.

Suzuki K, Deyashiki Y, et al. Characterization of a cDNA for human protein C inhibitor: a new member of the plasma serine protease inhibitor superfamily. J Biol Chem. 1987;262(2):611-616.

Suzuki K, Kise H, et al. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system. Semin Thromb Hemost. 2007;33(1):46-52.

Suzuki T, Nakajima K, et al. Metallothionein binding zinc inhibits nuclear chromatin decondensation of human spermatozoa. Andrologia. 1995;27(3):161-164.

Suzuki T, Suzuki K, et al. Metallothionein in human seminal plasma. Int J Urol. 1994;1(4):345-348.

Syner FN, Moghissi KS, et al. Isolation of a factor from normal human semen that accelerates dissolution of abnormally liquefying semen. Fertil Steril. 1975;26(11):1064-1069.

Tada T, Ohkubo I, et al. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J Histochem Cytochem. 1991;39(9):1221-1226.

Takeda H, Mizuno T, et al. Autoradiographic studies of androgen-binding sites in the rat urogenital sinus and postnatal prostate. J Endocrinol. 1985;104(1):87-92.

Tan JA, Marschkek B, French FS. Androgen receptor stimulated transcriptional activation mediated by GRE/PRE—like sequences within the prostatein C3 subunit gene, Endocrine Society Meeting, 1990.

Tauber PF, Zaneveld LJ, et al. Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. J Reprod Fertil. 1975;43(2):249-267.

Tauber PF, Zaneveld LJ, et al. Components of human split ejaculates. II. Enzymes and proteinase inhibitors. J Reprod Fertil. 1976;46(1):165-171.

Tauber PF, Zaneveld LJ. Coagulation and liquefaction of human semen. In: Hafez ESE, editor. Human semen and fertility regulation in men. St. Louis: Mosby, 1976.

Tawfic S, Goueli SA, et al. Androgenic regulation of the expression and phosphorylation of prostatic nucleolar protein B23. Cell Mol Biol Res. 1993;39(1):43-51.

Tawfic S, Goueli SA, et al. Androgenic regulation of phosphorylation and stability of nucleolar protein nucleolin in rat ventral prostate. Prostate. 1994;24(2):101-106.

Taylor RA, Risbridger GP. Prostatic tumor stroma: a key player in cancer progression. Curr Cancer Drug Targets. 2008;8(6):490-497.

Tenniswood M. Role of epithelial-stromal interactions in the control of gene expression in the prostate: an hypothesis. Prostate. 1986;9(4):375-385.

Thielen JL, Volzing KG, et al. Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers. Differentiation. 2007;75(1):49-61.

Thompson M, Lapointe J, et al. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate. 2008;68(11):1248-1256.

Thompson TC, Zhau HY, et al. Catecholamines are involved in the growth and expression of prostatic binding protein by rat ventral prostatic tissues. Prog Clin Biol Res. 1987;239:239-248.

Thomsen MK, Butler CM, et al. Sox9 is required for prostate development. Dev Biol. 2008;316(2):302-311.

Thomson AA. Role of androgens and fibroblast growth factors in prostatic development. Reproduction. 2001;121(2):187-195.

Thomson AA. Mesenchymal mechanisms in prostate organogenesis. Differentiation. 2008;76(6):587-598.

Thomson AA, Timms BG, et al. The role of smooth muscle in regulating prostatic induction. Development. 2002;129(8):1905-1912.

Timms BG. Prostate development: a historical perspective. Differentiation. 2008;76(6):565-577.

Tino WT, Huber MJ, et al. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA). Hybridoma. 2000;19(3):249-257.

Tisell LE. Effect of cortisone on the growth of the ventral prostate, the dorsolateral prostate, the coagulating glands and the seminal vesicles in castrated adrenalectomized and castrated non-adrenalectomized rats. Acta Endocrinol (Copenh). 1970;64(4):637-655.

Tomlinson DC, Freestone SH, et al. Differential effects of transforming growth factor-beta1 on cellular proliferation in the developing prostate. Endocrinology. 2004;145(9):4292-4300.

Tomlinson DC, Grindley JC, et al. Regulation of Fgf10 gene expression in the prostate: identification of transforming growth factor-beta1 and promoter elements. Endocrinology. 2004;145(4):1988-1995.

Troyer JK, Beckett ML, et al. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer. 1995;62(5):552-558.

Tsai YC, Harrison HH, et al. Systematic characterization of human prostatic fluid proteins with two-dimensional electrophoresis. Clin Chem. 1984;30(12 Pt. 1):2026-2030.

Tsujimura A, Koikawa Y, et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol. 2002;157(7):1257-1265.

Tullner WW. Hormonal factors in the adrenal-dependent growth of the rat ventral prostate. Natl Cancer Inst Monogr. 1963;12:211-223.

Tut TG, Ghadessy FJ, et al. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab. 1997;82(11):3777-3782.

Ulvsback M, Lindstrom C, et al. Molecular cloning of a small prostate protein, known as beta-microsemenoprotein, PSP94 or beta-inhibin, and demonstration of transcripts in non-genital tissues. Biochem Biophys Res Commun. 1989;164(3):1310-1315.

Uzgare AR, Xu Y, et al. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem. 2004;91(1):196-205.

Vafa AZ, Grover PK, et al. Study of activities of arginase, hexosaminidase, and leucine aminopeptidase in prostate fluid. Urology. 1993;42(2):138-143.

Valtonen-Andre C, Savblom C, et al. Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males. J Androl. 2008;29(3):330-337.

van der Graaf M, Schipper RG, et al. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. Magma. 2000;10(3):153-159.

van Leenders GJ, Schalken JA. Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer. Crit Rev Oncol Hematol. 2003;46(Suppl.):S3-10.

Vane JR, Botting RM. Pharmacodynamic profile of prostacyclin. Am J Cardiol. 1995;75(3):3A-10A.

Vashchenko N, Abrahamsson PA. Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur Urol. 2005;47(2):147-155.

Verhagen AP, Ramaekers FC, et al. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 1992;52(22):6182-6187.

Vermeulen A. The physical state of testosterone in plasma. In: James VHT, Serio M, Maratini L, editors. The endocrine function of the human testes, vol 1. New York: Academic Press; 1973:157-170.

Vermeulen A, Vrdonck L, Van der Straeten M, Orie N. Capacity of the TeBG in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab. 1969;29:1470-1480.

Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am. 1993;20(4):607-619.

Vignon F, Clavert A, et al. On the glandular origin of seminal plasma lipids in man. Andrologia. 1992;24(6):341-343.

Villoutreix BO, Getzoff ED, et al. A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci. 1994;3(11):2033-2044.

Vogelstein B, Pardoll DM, et al. Supercoiled loops and eucaryotic DNA replication. Cell. 1980;22(1 Pt. 1):79-85.

Von Euler US. Zur Kenntnis der pharmakologischen Wirkungen von Natirsekreten und Extrackten mannkicher accessorischer Geschlechtsdrusen. Arch Pathol Pharmakol. 1934;175:78-84.

Walsh PC, Gittes RF. Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens. Endocrinology. 1970;87(3):624-627.

Wang LG, Liu SM, et al. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Biochem Biophys Res Commun. 1999;259(1):21-28.

Wang MC, Valenzuela LA, et al. Purification of a human prostate specific antigen. Invest Urol. 1979;17(2):159-163.

Wang Y, Hayward S, et al. Cell differentiation lineage in the prostate. Differentiation. 2001;68(4–5):270-279.

Warot X, Fromental-Ramain C, et al. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development. 1997;124(23):4781-4791.

Watt KW, Lee PJ, et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A. 1986;83(10):3166-3170.

White IG, Darin-Bennett A, Poulos A. Lipids of human semen. In: Hafez ESE, editor. Human semen and fertility regulation in men. St. Louis: Mosby; 1976:144-152.

White MA. Change in pH of expressed prostatic secretion during the course of prostatitis. Proc R Soc Med. 1975;68(8):511-513.

Williams-Ashman HG. Regulatory features of seminal vesicle development and function. Curr Top Cell Regul. 1983;22:201-275.

Williams-Ashman HG, Corti A, Sheth AR. Formation and functions of aliphatic polyamines in the prostate and its secretions. In: Goland M, editor. Normal and abnormal growth of the prostates. Springfield (IL): Charles C. Thomas; 1975:222-239.

Williams-Ashman HG, Janne J, et al. New aspects of polyamine biosynthesis in eukaryotic organisms. Adv Enzyme Regul. 1972;10:225-245.

Williams-Ashman HG, Pegg AE, et al. Mechanisms and regulation of polyamine and putrescine biosynthesis in male genital glands and other tissues of mammals. Adv Enzyme Regul. 1969;7:291-323.

Williams-Ashman HG, Wilson J, et al. Transglutaminase reactions associated with the rat semen clotting system: modulation by macromolecular polyanions. Biochem Biophys Res Commun. 1977;79(4):1192-1198.

Williams RR, Fisher AG. Chromosomes, positions please!. Nat Cell Biol. 2003;5(5):388-390.

Wilson EM, Colvard DS. Factors that influence the interaction of androgen receptors with nuclei and nuclear matrix. Ann N Y Acad Sci. 1984;438:85-100.

Wilson JD, Griffin JE, et al. The role of gonadal steroids in sexual differentiation. Recent Prog Horm Res. 1981;37:1-39.

Wolff H, Bezold G, et al. Impact of clinically silent inflammation on male genital tract organs as reflected by biochemical markers in semen. J Androl. 1991;12(5):331-334.

Wright GL, Haley C, Beckett ML, Schellhammer PF. Expression of prostatic-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol. 1995;1:18-28.

Xiao Z, Adam BL, et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res. 2001;61(16):6029-6033.

Xin L, Lawson DA, et al. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A. 2005;102(19):6942-6947.

Yacoe ME, Sommer G, et al. In vitro proton spectroscopy of normal and abnormal prostate. Magn Reson Med. 1991;19(2):429-438.

Yan G, Fukabori Y, et al. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol. 1992;6(12):2123-2128.

Yan M, Song Y, et al. Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr. 2008;138(4):667-673.

Ylikomi T, Bocquel MT, et al. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. Embo J. 1992;11(10):3681-3694.

Yoshida K, Kawano N, et al. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans. Mol Hum Reprod. 2008;14(3):151-156.

Young CY, Andrews PE, et al. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry. 1992;31(3):818-824.

Young CY, Murtha PE, et al. Antagonism of androgen action in prostate tumor cells by retinoic acid. Prostate. 1994;25(1):39-45.

Yousef GM, Diamandis EP. Expanded human tissue kallikrein family—a novel panel of cancer biomarkers. Tumour Biol. 2002;23(3):185-192.

Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin Biochem. 2003;36(6):443-452.

Yousef GM, Obiezu CV, et al. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res. 1999;59(17):4252-4256.

Yu H, Diamandis EP, et al. Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. J Clin Lab Anal. 1994;8(4):251-253.

Yu H, Diamandis EP, et al. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem. 1994;27(2):75-79.

Yu H, Diamandis EP, et al. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat. 1994;32(3):291-300.

Yu M, Gipp J, et al. Sonic hedgehog-responsive genes in the fetal prostate. J Biol Chem. 2009;284(9):5620-5629.

Yurchenco PD, Amenta PS, et al. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 2004;22(7):521-538.

Zaneveld LJD, Chatterton RT. Biochemistry of mammalian reproduction. New York: J Wiley & Sons; 1982.

Zaneveld LJD, Tauber PF. Contributions of prostatic fluid components to the ejaculate. Prog Clin Biol Res. 1981;75A:265-277.

Zhang Y, Zhang J, et al. Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis. Development. 2008;135(4):775-784.

Zhigang Z, Wenlv S. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. World J Surg Oncol. 2004;2(1):13.